Academic Journal
Q2Bioorganic & Medicinal Chemistry
About Bioorganic & Medicinal Chemistry
Bioorganic & Medicinal Chemistry is a scholarly journal published by Elsevier Ltd. SCImago 2025 places it in Q2 with an SJR of 0.582 and an H-index of 198.
Its listed coverage is 1993-2026 and its research categories include Drug Discovery (Q2); Organic Chemistry (Q2); Pharmaceutical Science (Q2); Biochemistry (Q3); Clinical Biochemistry (Q3); Molecular Biology (Q3); Molecular Medicine (Q3). The 2025 dataset reports 294 documents and 2905 citations across the latest three-year reporting window.
Journal Metrics
Metrics can change by reporting year. Verify time-sensitive values with the publisher or indexing service.
Aims & Scope
The journal publishes research related to Synthesis and biological activity, Synthesis and Biological Evaluation, Diverse Scientific and Economic Studies, Chemical Synthesis and Analysis, Cancer therapeutics and mechanisms, Computational Drug Discovery Methods.
Recent Research Articles
Latest publications matched automatically by ISSN.
Design, synthesis, antitumor estimation, and molecular docking of new imidazothiazolediones as potential dual EGFR and IDO1 inhibitors and apoptosis stimulators
Marwa T. Sarg, Fatma G. Abdulrahman, Yasmin S. Sheta, Eman S. Nossier et al.
2026-12 · DOI: 10.1016/j.bmc.2026.118788Incorporation of PeT fluorescent units into the pharmacophore of atypical dopamine transporter inhibitors
Marie Louise Gram, Gisela Andrea Camacho-Hernandez, Amy Hauck Newman, Claus J. Loland et al.
2026-12 · DOI: 10.1016/j.bmc.2026.118786A novel ring-opened ebselen scaffold with potent anti-angiogenic activity against cancer: synthesis, biological evaluation, and molecular docking
Shuxiao Feng, Zongluo Zhang, Xuan Zhong, Jiahao Chen et al.
2026-12 · DOI: 10.1016/j.bmc.2026.118790Development of covalent agonists for the muscarinic acetylcholine receptor
Katrin Eitel, Philipp Risel, Jonas Kaindl, Jürgen Einsiedel et al.
2026-12 · DOI: 10.1016/j.bmc.2026.118783Design, synthesis and evaluation of fluorinated CYP1B1 inhibitors based on a trans-stilbene scaffold
Meixian Yang, Xin Liu, Xin Wei, Dachuan Qiu et al.
2026-12 · DOI: 10.1016/j.bmc.2026.118791Striking two targets with one scaffold via benzo[d]imidazole-isatin conjugates as potent dual VEGFR-2/c-MET antagonists
Mohamed El-Naggar, Rofaida Salem, Mona M. Kabeel, Ihsan A. Shehadi et al.
2026-12 · DOI: 10.1016/j.bmc.2026.118784Design, synthesis, and biological evaluation of novel phenylindole derivatives as P-gp inhibitors to overcome multidrug resistance in MCF-7/ADR cells
Zhikun Yang, Yingjia Ding, Keren Xu, Jiajia Han et al.
2026-12 · DOI: 10.1016/j.bmc.2026.118789Cancer cell membrane-coated superparamagnetic iron oxide nanoparticles as a theranostic platform for magnetic hyperthermia and MR imaging
Yuchen Yuan, Satoshi Okada, Akira Sumiyoshi, Kazuki Miura et al.
2026-12 · DOI: 10.1016/j.bmc.2026.118787Evaluating the outputs of ARAE-based molecular generative model for synthetic accessibility and BTK inhibition
Goutham Rajendran, Thanh-Hoang Nguyen-Vo, Hunter C. Murray, Robert A. Keyzers et al.
2026-12 · DOI: 10.1016/j.bmc.2026.118785Functional mapping of the Trypanosoma cruzi serinome by fluorophosphonate activity-based protein profiling
Jaime A. Isern, María Gabriela Mediavilla, Exequiel O.J. Porta, Marcelo L. Merli et al.
2026-12 · DOI: 10.1016/j.bmc.2026.118793Synthesis and biological evaluation of optically active Z250–1659 as a synthetic lethal agent against BAP1-deficient mesothelioma cells
Tomohiro Tsutsumi, Airi Wada, Hikari Yamamoto, Momoko Sato et al.
2026-12 · DOI: 10.1016/j.bmc.2026.118782Structure-based design of a 1H-Tetrazole-containing scaffold for Caspase-1 inhibition: Synthesis, biological evaluation, and preliminary in Vivo studies
Ajay L. Chandgude, Giovanni Loriga, Andrea Beccu, Fabio Arturo Iannotti et al.
2026-12 · DOI: 10.1016/j.bmc.2026.118794Design, synthesis and antitubercular evaluation of 2,5-disubstituted 1,3,4-oxadiazoles bearing a 3,5-dinitrophenyl pharmacophore
Václav Pflégr, Jiřina Stolaříková, Enikő Šikorová, Ildikó Szabó et al.
2026-11 · DOI: 10.1016/j.bmc.2026.118773Novel furo[2,3-d]pyrimidinones as direct thrombin inhibitors: Design, synthesis and biological evaluation
Atul N. Khadse, Hardik H. Savsani, Rupesh V. Chikhale, Shabnam Khan et al.
2026-11 · DOI: 10.1016/j.bmc.2026.118764Cationic amino acid-engineered radiopeptides for breast cancer targeting
Akanksha Jain, Manoj Kumar, R. Vasumathy, Amit Das et al.
2026-11 · DOI: 10.1016/j.bmc.2026.118780Design, synthesis and antiviral activity of ciclopirox (CPX) analogs against orthopoxvirus
D.M. Nirosh Udayanga, Ziyue Wang, Anil Pant, Ajit D. Jagtap et al.
2026-11 · DOI: 10.1016/j.bmc.2026.118775Novel hydrazone-linked pyridin-1-ium salts as multi-targeted agents for Alzheimer's disease: design, synthesis, in vitro and in silico studies
Hoang Tran, Le Quoc Tien, Tran Thi Thu Hien, Tran Xuan Vinh et al.
2026-11 · DOI: 10.1016/j.bmc.2026.118778Graphical abstract TOC
2026-11 · DOI: 10.1016/s0968-0896(26)00257-9Non-covalent dual HDAC6/proteasome inhibitors with anti-multiple myeloma activity
Yanmei Zhao, Xi Zou, Yidan Shao, Jingjing Sun et al.
2026-11 · DOI: 10.1016/j.bmc.2026.118762Editorial Board
2026-11 · DOI: 10.1016/s0968-0896(26)00254-3Reviews
Community Reviews
Version History
September 8, 2026 at 12:09 am
September 8, 2026